Skip to main content
Login
Contact
Subscribe
Search form
Search
The Punxsutawney Spirit
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Local Guide
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Corbus Pharma
(NQ:
CRBP
)
4.880
USD
-0.010 (-0.20%)
Streaming Delayed Price
/ Updated:
1:04 PM EST, Dec 10, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
164,085
Open
4.870
Bid (Size)
4.880 (3)
Ask (Size)
4.890 (3)
Prev. Close
4.890
Today's Range
4.780 - 4.960
52wk Range
4.180 - 9.110
Shares Outstanding
57,142,496
Dividend Yield
N/A
Performance
YTD
-25.50%
-25.50%
1 Month
+10.66%
+10.66%
3 Month
-7.92%
-7.92%
6 Month
-29.68%
-29.68%
1 Year
-27.81%
-27.81%
Top News
More News
Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System
December 09, 2019
from
GlobeNewswire News Releases
Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
November 18, 2019
from
GlobeNewswire News Releases
More News
Read More
Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London
November 12, 2019
from
GlobeNewswire News Releases
Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting
November 11, 2019
from
GlobeNewswire News Releases
Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
November 07, 2019
from
GlobeNewswire News Releases
Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019
November 04, 2019
from
GlobeNewswire News Releases
Interesting CRBP Put And Call Options For July 2020
November 19, 2019
category
Stocks
from
Market News Video
Analysts Predict 17% Upside For VTWG
November 19, 2019
category
ETFs
from
ETF Channel
Add Up The Parts: IBB Could Be Worth $139
October 17, 2019
category
ETFs
from
ETF Channel
Is Corbus Pharmaceuticals Stock a Buy?
November 07, 2019
category
Market News
,
CRBP
from
Motley Fool
Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals
November 07, 2019
category
Market News
,
CRBP
,
GWPH
from
Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.